Clinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia: Single-Blind Clinical Trial
Respiratory Pediatric Physiotherapy
+ Control Group
Infections+2
+ Lung Diseases
+ Pneumonia
Treatment Study
Summary
Study start date: February 3, 2018
Actual date on which the first participant was enrolled.This study focuses on evaluating the effectiveness of a treatment called Respiratory Pediatric Physiotherapy (RPP) for children who are hospitalized with pneumonia. Researchers aim to determine if RPP, when used alongside traditional methods like postural drainage and muscle compression, can help reduce the severity of pneumonia symptoms and shorten the length of hospital stays. The goal is to see if this combined approach can decrease the severity score by 1.5 points and reduce hospitalization by two days, potentially offering a more efficient treatment to improve recovery in young patients. Participants in this study will receive either the RPP treatment or the traditional methods of postural drainage and muscle compression. The results will be measured by observing changes in the clinical severity of pneumonia using a special scoring system known as the Wang score. By comparing these scores, researchers hope to identify the effectiveness of RPP and its impact on recovery times. The study is designed to provide reliable results with a high level of confidence, helping to determine if RPP should be more widely used in treating pneumonia in children.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.88 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 1 to 7 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Hospital Infantil de México Federico Gómez
Mexico City, MexicoOpen Hospital Infantil de México Federico Gómez in Google Maps